Coinbase
COIN
MARA Holdings
MARA
Vale SA
VALE
Meta Platforms
META
Adobe
ADBE
US Stock MarketDetailed Quotes
CRVO CervoMed
- 2.300
- +0.030+1.32%
Trading Jan 24 10:42 ET
18.98MMarket Cap-1.59P/E (TTM)
2.330High2.250Low23.25KVolume2.270Open2.270Pre Close53.05KTurnover0.51%Turnover RatioLossP/E (Static)8.25MShares26.37952wk High0.42P/B10.42MFloat Cap1.80052wk Low--Dividend TTM4.53MShs Float3375000000.000Historical High--Div YieldTTM3.52%Amplitude1.800Historical Low2.281Avg Price1Lot Size
About CervoMed Company
CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in1995 and is headquartered in Boston, MA.
Company Profile
SymbolCRVO
Company NameCervoMed
Listing DateNov 9, 2016
Founded1995
CEODr. John J. Alam, M.D.
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address20 Park Plaza,Suite 424
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02216
Phone1-617-744-4400
Websitehttp://www.cervomed.com
Company Executives
- Name
- Position
- Salary
- Dr. John J. Alam, M.D.
- Chief Executive Officer, President and Director
- 815.16K
- William R. Elder
- General Counsel, Corporate Secretary, Chief Financial Officer and Principal Accounting Officer
- 468.35K
- Dr. Robert Joseph Cobuzzi, Jr,PhD
- Chief Operating Officer and Director
- 703.12K
- Kelly Blackburn
- Senior Vice President, Clinical Development
- 465.74K
- Dr. Joshua S. Boger,PhD
- Chairman of the Board
- --
- Dr. Sylvie Gregoire,Pharm.D.
- Director
- 376.94K
- Frank Zavrl
- Independent Director
- 47.76K
- Dr. Marwan Noel Sabbagh, M.D.
- Independent Director
- 41.15K
- Jeffrey V. Poulton
- Independent Director
- 47.20K
- Jane H. Hollingsworth
- Independent Director
- 82.91K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.